Zurich Cantonal Bank’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Zurich Cantonal Bank’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,282	Closed	-$245K	–	2821
2023 Q2	$245K	Sell	5,282 -144	-3%	-$4.98K	﹤0.01%	1791
2023 Q1	$155K	Buy	5,426 +812	+18%	+$24.1K	﹤0.01%	2041
2022 Q4	$144K	Buy	+4,614	New	+$150K	﹤0.01%	2034

Zurich Cantonal Bank's DICE Position: Q3 2023 in Review

Zurich Cantonal Bank sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 5,282 shares — an estimated $245K sold.

Zurich Cantonal Bank first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $245K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Zurich Cantonal Bank reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Zurich Cantonal Bank sold 5,282 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $245K.
Zurich Cantonal Bank first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Zurich Cantonal Bank's DICE Therapeutics, Inc. Common Stock position peaked at $245K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Zurich Cantonal Bank's 13F filing for Q3 2023, filed 25 Oct 2023.